Venus Remedies has emerged as the first pharma company in the country to have received the prestigious Responsible Export Organisation (REO) Certification from the Confederation of Indian Industry (CII) following an elaborate screening and assessment process, the company said in a release.

A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess, the release further added.

Being the first pharmaceutical manufacturer to receive this certification, Venus Remedies is poised to set industry standards that enhance the competitiveness of Indian exports while focusing on expansion in new and existing markets.

Having a global footprint in more than 80 countries across five continents, including regulated and other markets like the UK, Italy, Australia, Germany, France, Kazakhstan, South Africa, Mexico, Israel, Hong Kong, Saudi Arabia, Philippines, Thailand, Oman. Venus Remedies aims to expand their global presence in at least 100 countries by 2025. VRL has 11 overseas marketing offices, more than 750 market authorisations and more than 450 pending authorisations in regulated and emerging markets apart from strategic alliances with leading multinationals.

Venus has more than 100 patent for its innovative research products worldwide. Recently awarded the WHO Good Distribution Practices (GDP) certification, Venus Remedies is also a recipient of the Authorised Economic Operator certification from the Directorate of International Customs, Central Board of Indirect Taxes & Customs.